Authors' comments on “branch retinal vein occlusion post severe acute respiratory syndrome coronavirus 2 vaccination”

Daisuke Nagasato¹, Hayato Tanaka², Yoshinori Mitamura³, Hitoshi Tabuchi^4
1 Department of Ophthalmology, Tsukazaki Hospital, Himeji, Hyogo; Department of Ophthalmology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima; Department of Technology and Design Thinking for Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
² Department of Ophthalmology, Tsukazaki Hospital, Himeji, Hyogo, Japan
³ Department of Ophthalmology, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan
⁴ Department of Ophthalmology, Tsukazaki Hospital, Himeji, Hyogo; Department of Technology and Design Thinking for Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

Correspondence Address:
Daisuke Nagasato,
68-1 Waku, Aboshi-ku, Himeji, Hyogo 671-1227
Japan

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2211-5056.361973